期刊
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
卷 29, 期 2, 页码 103-110出版社
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-2008-1063849
关键词
pulmonary Aspergillosis; voriconazole; aspergillus fumigatus
As the population of patients with prolonged neutropenia, those receiving hematopoictic stem cell transplantation or lung transplantation, or those with human immunodeficiency virus or acquired immunodeficiency syndrome continues to increase, the rising incidence of pulmonary aspergillosis is unlikely to diminish. Aspergillus species are ubiquitous in nature, have no geographic predilection, and the spectrum of disease they cause is myriad, ranging from noninvasive disease with colonization to disseminated disease with an associated high mortality rate. The extent of disease is thus largely responsible for both the choice and the duration of antifungal therapy. Recent years have seen an expansion of antifungal agents, with efficacy against Aspergillus requiring an understanding of the full spectrum of disease for them to be used appropriately. Diagnosis is often difficult because existing tests lack desired sensitivity or specificity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据